Real-time enrollment status for this nonsmall cell lung cancer stage iii clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:00 PM UTC
| NCT Number | NCT05696782 |
| Recruiting Status | Recruiting |
| Condition | Nonsmall Cell Lung Cancer Stage III |
| Phase | PHASE2 |
| Target Enrollment | 28 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Wake Forest University Health Sciences |
| Last Updated on CT.gov | September 22, 2026 (2 weeks ago) |
As of October 12, 2026: Clinical trial NCT05696782 is currently recruiting participants. This phase2 study for nonsmall cell lung cancer stage iii is actively seeking new participants at 2 locations across the United States. The study is sponsored by Wake Forest University Health Sciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05696782 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05696782 was last updated 2 weeks ago (September 22, 2026). HelloStudys verifies this status automatically.